Eingeschlossene Patienten: 23.533 (Stand 05. Mai 2025)
Amgevita® (Adalimumab)
251
Benepali® (Etanercept)
1278
Cimzia® (Certolizumab)
1050
Enbrel® (Etanercept)
2878
Erelzi® (Etanercept)
604
Flixabi® (Infliximab)
10
Hukyndra® (Adalimumab)
16
Hulio® (Adalimumab)
293
Humira® (Adalimumab)
2912
Hyrimoz® (Adalimumab)
271
Idacio® (Adalimumab)
71
Imraldi® (Adalimumab)
245
Inflectra™ (Infliximab)
16
Jyseleca® (Filgotinib)
173
Kevzara® (Sarilumab)
233
Kineret® (Anakinra)
89
MabThera® (Rituximab)
1459
Nepexto® (Etanercept)
101
Olumiant® (Baricitinib)
559
Orencia® (Abatacept)
997
Remicade® (Infliximab)
762
Remsima® (Infliximab)
27
Rinvoq® (Upadacitinib)
332
Rixathon® (Rituximab)
20
RoActemra® (Tocilizumab)
1381
Ruxience® (Rituximab)
1
Simponi® (Golimumab)
479
Truxima® (Rituximab)
6
Tyenne® (Tocilizumab)
62
Xeljanz® (Tofacitinib)
403
Yuflyma® (Adalimumab)
57
Zessly® (Infliximab)
2
Kontrollen
6495
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok